Chemical synthesis study demonstrates efficient deuterodehalogenation of aryl halides using a heterogeneous copper catalyst and heavy water, highlighting a scalable route for drug labelling.
There is growing potential and interest in the development of precise and practical deuterium labelling methodologies using an easy-handling deuterated source for alkylarenes and methylarenes. Here we report a heterogeneous copper catalyst that enables dehalogenative deuteration of aromatic halides using D 2 O as a deuterium source. This methodology showed a broad substrate scope and good functional group tolerance. Using inexpensive and easy-handling D₂O as the deuterium source under mild conditions allows for the preparation of deuterated building blocks, representative drugs and late-stage labelling of bioactive molecules with high deuterium incorporation. In this reaction, DMF not only is a solvent, but also a precursor of CO surrogate and a base, which is essential to the deuterium incorporation. This methodology represents a practical and scalable deuteration (demonstrated by the synthesis of deuterium labelling products on the 50 grams) and the air- and water-stable copper catalyst straightforwardly enables efficient labelling. A heterogeneous copper catalyst that enables dehalogenative deuteration of aromatic halides using D 2 O as a deuterium source was achieved. “One stone, three birds.” In this reaction, DMF not only is a solvent, but also a CO surrogate and a base, which is essential to the deuterium incorporation. “One catalyst, three reactions.” In this transformation, the prepared copper catalyst catalyzed the DMF decomposition reaction, WTGS reaction and dehalogenative deuteration reaction.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: